The legal battle between prominent Indonesian celebrities and beauty entrepreneurs reached a critical juncture at the South Jakarta District Court on Wednesday, April 15, 2026, as Dr. Oky Pratama took the stand as a key witness. The proceedings, which stem from a lawsuit filed by actress and social media personality Nikita Mirzani against fellow skincare mogul Reza Gladys, center on allegations of an "Unlawful Act" (Perbuatan Melawan Hukum or PMH). The courtroom was filled with legal representatives and media personnel as Dr. Oky, a well-known figure in the Indonesian aesthetic medicine industry, detailed his involvement in the friction that has captivated the public for several months.
During his testimony, Dr. Oky Pratama, who is the founder of Bening’s Clinic and a close associate of both parties, clarified his role as a self-described "communication bridge" between the plaintiff and the defendant. According to his statement before the panel of judges, the tension between Nikita Mirzani and Reza Gladys escalated significantly during the latter half of 2024, leading to the current litigation. In addition to Dr. Oky, Nikita’s legal team also presented Dhea Hanifa Putri, Nikita’s personal manager, to provide further context regarding the professional and personal fallout resulting from the dispute.
The Testimony of Dr. Oky Pratama: A Bridge Under Pressure
Dr. Oky’s testimony focused primarily on the timeline of communication that occurred between September and October 2024. He revealed that during this period, Reza Gladys repeatedly reached out to him in an attempt to secure a direct meeting with Nikita Mirzani. The witness noted that the frequency of these requests indicated a high level of urgency from the defendant’s side.
"I was contacted continuously by Reza Gladys throughout September and October of 2024," Dr. Oky stated in the courtroom. "She expressed a strong desire to be facilitated in a face-to-face meeting with Nikita. At the time, I perceived my role as a mediator who could perhaps help de-escalate the rising tensions before they reached the legal stage."
The witness explained that while he attempted to convey these requests to Nikita, the atmosphere was already fraught with hostility. The legal team representing Nikita Mirzani questioned Dr. Oky extensively on the nature of these communications, seeking to establish whether the defendant’s actions constituted an admission of wrongdoing or an attempt to suppress information regarding the quality and legality of certain skincare products marketed by Gladys’s brand.
Background and Chronology of the Dispute
The roots of the conflict between Nikita Mirzani and Reza Gladys are deeply intertwined with the competitive and often volatile landscape of the Indonesian skincare industry. While the current trial focuses on the civil aspect of an Unlawful Act (PMH), the friction reportedly began with allegations concerning the safety and licensing of beauty products.
The timeline of the dispute can be traced back to mid-2024:
- August 2024: Rumors began circulating on social media regarding the ingredients used in several high-profile local skincare brands. Nikita Mirzani, known for her vocal stance on consumer protection and transparency, began making public statements about "over-claimed" products and brands that allegedly lacked proper BPOM (National Agency of Drug and Food Control) certification.
- September 2024: Tensions peaked when Nikita specifically alluded to products associated with Reza Gladys. It was during this month that Dr. Oky Pratama was first pulled into the conflict as a mediator.
- October 2024: Despite Dr. Oky’s attempts to facilitate a meeting, the parties failed to reach an amicable resolution. Legal notices were exchanged, and the rhetoric on social platforms intensified.
- Late 2024 – Early 2025: Nikita Mirzani officially filed a police report and a subsequent civil lawsuit. The civil lawsuit, which is currently being heard, seeks damages for what the plaintiff describes as a violation of legal norms and ethical standards in business.
- April 15, 2026: The South Jakarta District Court convenes for the evidentiary phase, calling upon Dr. Oky Pratama and Dhea Hanifa Putri to testify.
Understanding the Legal Concept of "Perbuatan Melawan Hukum" (PMH)
In the context of Indonesian law, a lawsuit for an Unlawful Act is grounded in Article 1365 of the Indonesian Civil Code (Burgerlijk Wetboek). To succeed in such a claim, the plaintiff must prove several key elements:
- The existence of an unlawful act: The defendant must have committed an act that violates the law, the legal rights of others, or the principles of decency and professional conduct.
- Fault or Negligence: There must be a demonstrable error or omission on the part of the defendant.
- Damages: The plaintiff must have suffered actual loss, whether material (financial) or immaterial (reputational).
- Causality: There must be a direct link between the unlawful act and the damages suffered.
Nikita Mirzani’s legal team argues that Reza Gladys’s business practices and the subsequent fallout caused significant reputational damage to Nikita, who has built a brand around being a "truth-teller" in the industry. Conversely, the defense argues that the lawsuit is an attempt to stifle competition and that all products were in compliance with existing regulations.
The Role of the Skincare Industry and BPOM Oversight
A significant subtext of this trial is the broader issue of skincare regulation in Indonesia. The Indonesian beauty market has seen exponential growth over the last five years, with hundreds of new local brands entering the fray. However, this growth has been accompanied by concerns regarding "white-labeling"—where entrepreneurs buy generic formulas and rebrand them—and the potential for misleading marketing.
The National Agency of Drug and Food Control (BPOM) has been under increasing pressure to tighten its oversight. In previous statements related to this case, Nikita Mirzani hinted that some products under investigation might contain ingredients that, while effective in the short term, do not meet long-term safety standards or were marketed using unauthorized claims.
The testimony of Dhea Hanifa Putri, Nikita’s manager, further supported the claim that the dispute had professional consequences. Dhea testified about the impact the conflict had on Nikita’s endorsement contracts and the mental stress caused by the ongoing legal uncertainty. She emphasized that the decision to pursue a lawsuit was not taken lightly but was seen as a necessary step to protect Nikita’s professional integrity.
Implications for the Beauty Mogul Community
The outcome of this trial is expected to set a significant precedent for the Indonesian beauty industry. For years, the sector has operated in a gray area where celebrity influence often outpaces regulatory scrutiny. A verdict in favor of Nikita Mirzani could signal a new era of accountability, where influencers and entrepreneurs are held to stricter standards regarding the claims they make about their products.
Industry analysts suggest that the "skincare wars" among Indonesian socialites often blur the lines between personal vendettas and genuine consumer advocacy. Dr. Oky Pratama’s involvement is particularly noteworthy because he occupies a unique space as both a medical professional and a commercial entity. His testimony reflects the difficult position many industry insiders find themselves in when two powerful figures clash.
Official Responses and Courtroom Atmosphere
Following the session, Nikita Mirzani’s lead counsel expressed satisfaction with the day’s proceedings. "Dr. Oky’s testimony confirms that there was an active effort from the other side to resolve something that they clearly felt was a problem. It establishes the timeline of events and shows that our client was not the aggressor, but rather someone responding to a situation that had already gone too far," the attorney told reporters outside the courthouse.
On the other side, the legal team for Reza Gladys maintained their client’s innocence. They argued that the desire to meet with Nikita was a gesture of good faith intended to clear up misunderstandings, rather than an admission of any unlawful act. They characterized the lawsuit as an "exaggeration of professional disagreements" and expressed confidence that the evidence would ultimately favor the defendant.
The court has scheduled the next hearing for the following week, where more expert witnesses are expected to be called, including potentially representatives from regulatory bodies or independent dermatologists to discuss the technical aspects of the products in question.
Broader Impact and Public Perception
The public reaction to the trial has been polarized. On social media platforms like Instagram and TikTok, fans of both women have engaged in heated debates. Some view Nikita Mirzani as a crusader for consumer safety, while others see the litigation as an unnecessary escalation of a personal rivalry.
Beyond the gossip, however, the case highlights the maturing of the Indonesian legal system in handling disputes involving digital assets, personal branding, and modern commerce. As the trial continues, it serves as a reminder that in the age of social media, reputation is a valuable commodity, and the law is increasingly being used to define the boundaries of professional conduct in the digital marketplace.
The South Jakarta District Court will continue to deliberate on the evidence presented by Dr. Oky Pratama and other witnesses. As the legal process unfolds, the beauty industry remains on high alert, waiting to see how the court will define "unlawful acts" in the context of one of the country’s most lucrative and competitive sectors. The resolution of this case will likely influence how skincare brands are marketed and how disputes between public figures are managed for years to come.